Management of rheumatic complications of ICI therapy: a rheumatology viewpoint.

Volume: 58
Published: Dec 1, 2019
Abstract
Since immune checkpoint inhibitors became the standard of care for an increasing number of indications, more patients have been exposed to these drugs and physicians are more challenged with the management of a unique spectrum of immune-related adverse events (irAEs) associated with immune checkpoint inhibitors. Those irAEs of autoimmune or autoinflammatory origin, or both, can involve any organ or tissue, but most commonly affect the...
Paper Details
Title
Management of rheumatic complications of ICI therapy: a rheumatology viewpoint.
Published Date
Dec 1, 2019
Volume
58
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.